Stockscreener 앱 받기
4.37
0.46%
-0.02
시간 외 거래:
4.37
Polypid Ltd 주식(PYPD)의 최신 뉴스
PolyPid Ltd. (NASDAQ:PYPD) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
PolyPid (PYPD) director discloses stock options on 17,456 shares - Stock Titan
PolyPid (PYPD) director details shares and vested stock options - Stock Titan
PolyPid (PYPD) CEO details stock and option holdings in Form 3 - Stock Titan
PolyPid (PYPD) deputy CEO discloses extensive employee stock options - Stock Titan
PolyPid Ltd. (NASDAQ:PYPD) Q4 2025 earnings call transcript - MSN
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention - TipRanks
Is PolyPid Ltd likely to announce a buybackEarnings Growth Report & Step-by-Step Trade Execution Guides - baoquankhu1.vn
PolyPid granted $4.3M waiver from FDA for D-Plex application - TipRanks
PolyPid receives $4.3M FDA fee waiver for D-PLEX100 application - Investing.com
Polypid receives PDUFA fee waiver from FDA for D-Plex100's new drug application - marketscreener.com
$4.3M FDA fee waived for new drug to prevent surgical infections - Stock Titan
PolyPid Ltd. (NASDAQ:PYPD) Sees Large Drop in Short Interest - MarketBeat
PolyPid Ltd Stock (ISIN: US70450B1035) Surges on Analyst Optimism: 260% Upside Forecast Signals Majo - AD HOC NEWS
Wall Street Zen Upgrades PolyPid (NASDAQ:PYPD) to Hold - MarketBeat
PolyPid at Citizens Life Sciences: Strategic Moves and Market Expansion - Investing.com India
PolyPid at Citizens Life Sciences: Strategic Moves and Market Expansion By Investing.com - Investing.com Australia
PYPD: NDA submission for D-PLEX₁₀₀ is imminent, backed by strong Phase 3 efficacy data - TradingView
How PolyPid Ltd. stock performs in stagflation2026 Short Interest & Stepwise Trade Execution Plans - Naître et grandir
PYPD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
PolyPid (NASDAQ:PYPD) Downgraded by Wall Street Zen to "Sell" - MarketBeat
PYPD PE Ratio & Valuation, Is PYPD Overvalued - Intellectia AI
PolyPid Announces Participation in Upcoming Investor Conferences - Bitget
PolyPid Ltd. Auditor Raises 'Going Concern' Doubt - marketscreener.com
PolyPid Ltd. (NASDAQ:PYPD) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Is PolyPid Ltd. stock forming a triangle patternJuly 2025 Recap & Daily Profit Maximizing Trade Tips - mfd.ru
Does PolyPid Ltd. have high return on assetsMarket Sentiment Report & Long-Term Growth Portfolio Plans - mfd.ru
Is PolyPid Ltd. stock technically oversoldJuly 2025 Analyst Calls & Weekly Top Gainers Trade List - mfd.ru
PYPD SEC FilingsPolypid Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan
Polypid targets rolling NDA submission for D-PLEX100 by end of Q1 2026 amid advanced US partnership talks - MSN
Aug Decliners: Is PolyPid Ltd likely to announce a buyback2025 Technical Patterns & Fast Gain Swing Trade Alerts - baoquankhu1.vn
PolyPid Ltd. (NASDAQ:PYPD) Short Interest Up 44.8% in January - MarketBeat
Research Analysts Issue Forecasts for PolyPid Q1 Earnings - Defense World
HC Wainwright Predicts PolyPid's Q1 Earnings (NASDAQ:PYPD) - MarketBeat
When Will PolyPid Ltd. (NASDAQ:PYPD) Turn A Profit? - Yahoo Finance
PolyPid Q4 Earnings Call Highlights - Defense World
PolyPid Ltd. (NASDAQ:PYPD) Q4 2025 Earnings Call Transcript - Insider Monkey
Is PolyPid Ltd. likely to announce a buybackJuly 2025 Recap & Low Risk High Win Rate Picks - mfd.ru
FY2028 Earnings Forecast for PolyPid Issued By HC Wainwright - MarketBeat
PolyPid Earnings Call Flags Big 2026 Catalyst - The Globe and Mail
PolyPid (PYPD) Analyst Rating Reiteration by HC Wainwright | PYP - GuruFocus
PolyPid (NASDAQ:PYPD) Earns Buy Rating from HC Wainwright - MarketBeat
PolyPid (NASDAQ:PYPD) Releases Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat
Earnings call transcript: PolyPid’s Q4 2025 results miss EPS forecasts By Investing.com - Investing.com Australia
Earnings call transcript: PolyPid’s Q4 2025 results miss EPS forecasts - Investing.com India
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results - The Manila Times
PolyPid Ltd. Advances U.S. Partnership Talks for D-PLEX₁₀₀ Following Positive FDA Feedback and Plans Rolling NDA Review - Quiver Quantitative
PolyPid (PYPD) deepens 2025 loss while D-PLEX100 advances toward FDA NDA filing - Stock Titan
PolyPid (PYPD) Q4 2025 Earnings Call Transcript - The Globe and Mail
Preview: PolyPid's Earnings - Benzinga
Will PolyPid Ltd. stock recover after earnings2025 AllTime Highs & Capital Protection Trade Alerts - mfd.ru
Aug Closing: Is PolyPid Ltd likely to announce a buybackMarket Activity Summary & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
PolyPid (PYPD) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
PolyPid Ltd. (NASDAQ:PYPD) Sees Large Decrease in Short Interest - MarketBeat
1.20%
0.06%
자본화:
|
볼륨(24시간):